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Background: Epigallocatechin-3-gallate (EGCg) with its potent anti-oxidative capabilities is known for its beneficial
effects ameliorating oxidative injury to cardiac cells. Although studies have provided convincing evidence to
support the cardioprotective effects of EGCg, it remains unclear whether EGCg affect trans-membrane signalling in
cardiac cells. Here, we have demonstrated the potential mechanism for cardioprotection of EGCg against
H2O2-induced oxidative stress in H9c2 cardiomyoblasts.
Results: Exposing H9c2 cells to H2O2 suppressed cell viability and altered the expression of adherens and gap
junction proteins with increased levels of intracellular reactive oxygen species and cytosolic Ca2+. These detrimental
effects were attenuated by pre-treating cells with EGCg for 30 min. EGCg also attenuated H2O2-mediated cell cycle
arrest at the G1-S phase through the glycogen synthase kinase-3β (GSK-3β)/β-catenin/cyclin D1 signalling pathway.
To determine how EGCg targets H9c2 cells, enhanced green fluorescence protein (EGFP) was ectopically expressed
in these cells. EGFP-emission fluorescence spectroscopy revealed that EGCg induced dose-dependent fluorescence
changes in EGFP expressing cells, suggesting that EGCg signalling events might trigger proximity changes of EGFP
expressed in these cells.
Proteomics studies showed that EGFP formed complexes with the 67 kD laminin receptor, caveolin-1 and -3,
β-actin, myosin 9, vimentin in EGFP expressing cells. Using in vitro oxidative stress and in vivo myocardial ischemia
models, we also demonstrated the involvement of caveolin in EGCg-mediated cardioprotection. In addition,
EGCg-mediated caveolin-1 activation was found to be modulated by Akt/GSK-3β signalling in H2O2-induced H9c2
cell injury.
Conclusions: Our data suggest that caveolin serves as a membrane raft that may help mediate cardioprotective
EGCg transmembrane signalling.
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Green tea polyphenols (GTPs) have potent antioxidant
and radical-scavenging properties, which may partially
account for their cardioprotective effects [1]. The major
catechins in GTPs include epicatechin (EC), epigallocatechin
(EGC), epicatechin-3-gallate (ECG), and epigallocatechin-
3-gallate (EGCg) [1,2]. EGCg is the most physiologically* Correspondence: ymlion@dragon.nchu.edu.tw
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reproduction in any medium, provided the orpotent compound, and primarily accounts for the biological
effects of green tea. Two recent reports using two differ-
ent rat myocardial ischemic models of MI (myocardial
infarction) [3] and IR (ischemia reperfusion) [4] associated
with left anterior descending (LAD) coronary artery ligation
have demonstrated that GTPs can efficiently improve cell
viability during myocardial ischemic injury. Other studies
of myocardial injury have also suggested that the cardiopro-
tective effect of GTPs is associated with the scavenging of
active-oxygen radicals, the modulation of redox-sensitive
transcription factors (e.g., NFκB, AP-1), the reduction of
STAT-1 activation and Fas receptor expression, an increase
in NO production, and the exertion of positive inotropictd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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evidence to support the cardioprotective effects of GTPs,
it remains unclear whether GTPs affect trans-membrane
signalling in cardiac cells.
A growing body of evidence has demonstrated that
multiple signal transduction events for cardioprotection
are mediated via signalling microdomains, such as lipid
rafts or caveolae, on the plasma membrane of cardiac
cells [10,11]. Caveolae are a subset of lipid rafts enriched
in the protein caveolin (Cav) [12]. There are three iso-
forms of Cav, Cav-1, Cav-2 and Cav-3 [13], each of
which functions as a scaffolding protein to organize
and regulate membrane receptors and lipid-modified
signalling molecules [14-16]. Cav-3 is the muscle-specific
isoform in cardiac myocytes, whereas Cav-1 and Cav-2
are present in other cell types in the heart [17]. A study
using in vitro and in vivo models of myocardial injury
demonstrated that modification of the membrane
structure and composition triggers Src activation and
Cav-1 phosphorylation, resulting in cardioprotection
[18]. More recently, another study with Cav-3 knock-
out mice subjected to IR injury has shown that the ex-
pression of Cav-3 in cardiac myocytes is essential for
isoflurane-induced cardioprotection from myocardial
ischemic injury [19]. These data also suggested that Cav
may mediate the beneficial actions of a variety of cardi-
oprotective agents [19].
In this study, we examined the potential mechanism
for EGCg-mediated cardioprotection in an H2O2-induced
oxidative stress model of myocardial ischemia injury using
H9c2 rat cardiomyoblasts. We first verified that the cardi-
oprotection of EGCg is mediated by decreasing reactive
oxygen species (ROS) and cytosolic Ca2+ and by prevent-
ing alterations in the protein expression of the adherens
molecules β-catenin and N-cadherin and the gap junction
protein connexin 43 (Cx43) in cardiac cells. In addition,
EGCg was found to prevent H2O2-induced cell cycle arrest
at G1-S phase via the glycogen synthase kinase-3β/β-
catenin/cyclin D1 signalling pathway. To further clarify
the putative mechanism underlying EGCg transmembrane
signalling in cardiac cells, enhanced green fluorescence
protein (EGFP) was ectopically expressed in H9c2 cells.
EGFP-emission fluorescence spectroscopy indicated that
Triton X-100-resistant microdomains (i.e., lipid rafts) on
the cell membrane may take part in the transmission of
EGCg signalling to protect cardiac cells from oxidative
stress. Using an in vitro H2O2-induced oxidative stress
model in H9c2 cells and an in vivo rat model of myocardial
ischemia, we demonstrated the involvement of Cav
in GTPs-mediated cardioprotection. In addition, we
showed that EGCg-mediated Cav-1 activation could be
modulated by Akt/GSK-3β signalling in H2O2-induced
H9c2 cell injury. Taken together, our data suggest that




H9c2 cell lines were purchased from American Type
Culture Collection (ATCC, CRL-1446) (Rockville, MD).
All reagents used were ACS or MB grade. EGCg, purchased
from Sigma, was prepared as a stock solution of 10 mM by
dissolving the compound in deionized water.
Cell culture, EGCg and/or H2O2 treatments, MTT assay
H9c2 cells were cultured in Dulbecco’s modified essen-
tial medium (DMEM, Gibco, Invitrogen Taiwan Ltd.,
Taipei, Taiwan) containing 10% fetal bovine serum
(FBS) (Gibco), 25 mM D-glucose, 2 mM L-glutamine,
1 mM sodium pyruvate, 1% streptomycin (100 μg/ml)
(Gibco), and 1% penicillin (100 U/ml) (Gibco) at pH 7.4
in a 5% CO2 incubator at 37°C. Cell viability was mea-
sured using the MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) cell proliferation assay
(ATCC, Manassas, VA, USA). Cells (105) were seeded
onto 6-cm plates in DMEM-10% FBS. After adhering
overnight, the cells were changed to serum-free medium
with or without EGCg for 30 min in a 5% CO2 incubator
at 37°C and then washed with phosphate buffer solution
(PBS). The washed cells were treated with different con-
centrations of H2O2 in serum-free DMEM for 30 min in
a 5% CO2 incubator at 37°C. After washing with PBS,
the cells were incubated in serum-free DMEM for 24 h
in a 5% CO2 incubator at 37°C. After 24 h incubation,
MTT was then added to the cells at a final concentration
of 0.5 mg/ml and the mixture was incubated at 37°C for
4 h. The optical density of the purple MTT formazan
product was measured at 570 nm using a microplate
reader (Anthos 2000, Austria).
Determination of cellular Ca2+ levels
Fura 2-AM (fura 2-tetra-acetoxymethyl ester; Molecular
Probes, Eugene, OR) was used as the fluorescent indi-
cator. H9c2 cells were dissolved in PBS containing
2 mM fura 2-AM and incubated for 45 min at room
temperature and then for 30 min at 37°C, during which
time the fura 2-AM was trapped inside by esterase
cleavage. The cells were then washed twice with PBS
and diluted to a density of 2 × 106 cells/ml in PBS. Re-
cordings were made in a Perkin-Elmer LS 50B spectro-
fluorimeter equipped with an accessory to measure Ca2+
(Beaconsfield, Buckinghamshire, England). The dye trapped
inside the cells was excited every second by exposure to
alternating 340 and 380 nm light beams and the intensity
of light emission at 510 nm was measured, allowing the
monitoring of both the light intensity and the 340 nm
fluorescence/380 nm ratio (F340/F380). The 340/380 ratio
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levels of [Ca2+]i as described previously [20], using a Kd
of 0.14 μM [21]:
Ca2þ
 
i ¼ Kd  R‐Rminð Þ= Rmax‐Rð Þ  Sf2=Sb2
where Rmin and Rmax are the ratios measured by the
release of intracellular dye with 2 mM EGTA in 0.1%
Triton X-100 (Rmin) followed by the addition of 2.1 mM
Ca2+ (Rmax), whereas Sf2/Sb2 is the ratio of the 380 nm sig-
nals in Ca2+-free and Ca2+-replete solutions, respectively.
Measurement of intracellular ROS generation by
fluorescence spectrophotometry
Intracellular ROS levels were assessed using 2′,7′-
dichlorofluorescein diacetate (DCF-DA) [21]. Cells
(1.2 × 106) loaded with DCF-DA in 3 ml PBS at a final
concentration of 10 μM were incubated at 37°C for 1 h.
After incubation, the cells were then washed three times
with PBS by centrifugation at 300 × g at 4°C for 5 min.
The cells re-suspended with PBS and brought to a density
of 105 cells/ml were measured for DCF-DA fluorescence
changes every 10 min after the addition of H2O2 or EGCg
by fluorescence spectrophotometry. The fluorescence
excitation maximum for DCF-DA was 495 nm, and the
corresponding emission maximum was 527 nm.
Cell cycle phase determination
H9c2 cells (107) were seeded in a 10-cm dish in DMEM-
0.2% FBS and cultured in a CO2 incubator at 37°C for 24 hr.
The cells were then changed to fresh medium, trypsinized,
and centrifuged. The pellet was washed and re-suspended
in 1 ml of pre-chilled PBS, fixed by the gradual addition of
3 ml of 95% ethanol, and stored in a deep freezer (-20°C)
overnight. The cells were then washed three times by
centrifugation and re-suspended in pre-chilled PBS. To
stain the cells with propidium iodide (PI), the cells were re-
suspended in PBS containing 0.1% Triton X-100, 20 μg/ml
of PI, and 0.2 mg/ml of RNase A and incubated for 30 min
at room temperature in the dark. Samples were analyzed on
a flow cytometer (FC500 Flow Cytometry System, Beckman
Coulter, Inc.) with a 488 nm excitation laser. The cell cycle
phases were determined using the software provided with
the instrument (CXP Software, Beckman Coulter, Inc.) [22].
Western blots
The sample preparation for SDS-PAGE and electro-
transfer was as described previously [23,24]. The primary
antibodies used were mouse monoclonal antibodies against
β-actin (C4) (sc-47778), human N-cadherin (H-63) (sc-7939),
human-β-catenin (9 F2) (sc-47752), human GSK-3β (H-76)
(sc-9166), human pGSK-3β (pY-216) (sc-135653), human
cyclin D1 (DSC-6) (sc-20044), Cav-3 (A-3) (sc-5310),
rat-nCx43 (D-7) (sc-13558), and rabbit GAPDH (6C5)(sc-32233) (all from Santa Cruz and all 1: 1000 dilution);
goat polyclonal anti-human Laminin-R antibody (F-18)
(sc-21534) (Santa Cruz; 1: 1000 dilution); and rabbit
polyclonal antibodies raised against human Cav-1 (N-20)
(sc-894), human Akt1 (H-136) (sc-8312), human Ser 9
phosphorylated GSK-3β (Ser 9) (sc-11757), pCav-1 (Tyr 14)
(sc-101653) (Santa Cruz; 1: 1000 dilution), human Ser 473
phosphorylated Akt1 (SAB4504331) (Sigma, 1: 500 dilution),
and rat Cx43 (71-0700) (Zymed, Invitrogen; 1: 1000 dilution).
After 3 × 10 min washes with PBS containing 0.05%
Tween-20, the membrane was incubated for 2 h at 4°C
with alkaline phosphatase-conjugated goat anti-rabbit,
donkey-anti-goat, or rabbit-anti-mouse IgG antibodies
(Santa Cruz; 1:5000 dilution), and the bound antibody
was detected using 5-bromo-4-chloro-3-indolyl phosphate-
nitro blue tetrazolium.
EGFP-expressing H9c2 and fluorescence measurements
EGFP-expressing H9c2 cells were generated by co-
transfecting pEGFP-N1 (PT3027-5) vector with Lipofecta-
mine 2000 (Invitrogen) into H9c2 cells. The fluorescence
changes in transformed cells were measured in a
Perkin-Elmer LS 50B spectrofluorimeter (Beaconsfield,
Buckinghamshire, England). The fluorescence excitation
maximum for EGFP was 488 nm, and the corresponding
emission maximum was 507 nm [20].
Immunoprecipitation and immunoblotting
EGFP expressed H9c2 cells were lysed with pre-chilled
RIPA buffer containing 50 mM Tris–HCl, pH 7.4, 150 mM
NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 5 mM
EDTA, 0.02 mM EGTA, 1% phenylmethanesulfonyl fluor-
ide, and a cocktail of protease inhibitors. The cell lysates
were diluted with pre-chilled PBS to a volume of 500 μl
and a concentration of 5 mg/ml and incubated overnight
at 4°C with 25 μg of rabbit anti-EGFP (PG-10013, Genesis
Biotech Inc., Taipei, Taiwan). 50 μl protein G Sepharose
4 Fast flow (GE Healthcare UK Ltd., England) was then
added, and the mixture was incubated for 1 h at 4°C. After
centrifugation, the pellet was washed with RIPA buffer
followed by Tris-OH buffer (50 mM, pH 8.0). The samples
dissolved in reducing buffer containing 1% SDS, 100 mM
dithiothreitol, 50 mM Tris-OH, pH 7.5 were used for mo-
lecular identification of the protein complexes that formed
with EGFP in the overexpressed cells by SDS-PAGE,
followed by immunoblotting, as described above. In
addition, protein bands on the SDS-PAGE gels were cut
out for molecular identification by acquiring MALDI-MS
spectra at the Proteomics center at National Chung-Hsing
University (Taichung, Taiwan) (Additional file 1: Figure S1).
Protein separation by 2-DE and isoelectric focusing (IEF)
After co-immunoprecipitation, the protein complexes
conjugated with EGFP were separated by two-dimensional
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strips (pH 3-10, 13 cm) were rehydrated with 450 μg pro-
tein at room temperature overnight (at least 12 h). IEF was
performed using an IPGphor 3 apparatus (GE healthcare)
for a total of 17 kVh at 20°C. After IEF, strips were
equilibrated in 6 M urea, 75 mM Tris–HCl (pH 8.8), 29.3%
(v/v) glycerol, 2% (w/v) SDS and 0.002% (w/v) bromo-
phenol blue with 65 mM DTT for 15 min and in the
same buffer with 240 mM iodoacetamide for next 15 min.
Strips were then transferred onto 10% polyacrylamide gels
and sealed with 0.5% (w/v) low-melting-point agarose in
SDS running buffer containing 0.02% (w/v) bromophenol
blue. The gels were run in a PROTEAN® II xi gel tank
(Bio-Rad) at 35 mA per gel at 20°C until the dye reached
the bottom of the gels. Gels were stained with Bio-safe™
Coomassie G-250 Stain (Bio-Rad) according to the manu-
facturer’s protocol. Stained gels were scanned using
Scanmaker 9800XL (Microtek) and analyzed using
ImageMaster™ 2D Platinum 7.0 (GE healthcare). The
proteins of interest were cut out for molecular identi-
fication by acquiring MALDI-MS spectra.
RNA extraction and semi-quantitative RT-PCR
The procedures for RNA extraction and semi-quantitative
reverse transcription polymerization chain reaction
(semi-quantitative RT-PCR) have been described previously
[20]. The primers used were GAPDH, (forward) 5-ACC
ACA GTC CAT GCC ATC AC-3, (reverse) 5-TCC ACC
ACC CTG TTG CTG TA-3, product size 452 bp; Cav-1,
(forward) 5-CTA CAA GCC CAA CAA CAA GGC-3,
(reverse) 5-AGG AAG CTC TTG ATG CAC GGT-3,
product size 342 bp; Cav-2, (forward) 5-GCT CAA CTC
GCA TCT CAA GCT-3, (reverse) 5-TCT GTC ACA CTC
TTC CAT ATT-3, product size 260 bp; Cav-3, (forward) 5-
GGA CAT TGT GAA GGT GGATTT-3, (reverse) 5-GCA
CTG GAT CTC AAT CAG GTA-3, product size 247 bp.
The correct sequences for all genes were confirmed by
alignment with the reported sequence for each gene.
A rat model of myocardial ischemia involving LAD ligation
Male Sprague–Dawley rats (200-250 g), aged 8-9 weeks,
were randomly divided into three groups: a sham control
group, a group that underwent LAD ligation without GTP
supplementation, and a group that underwent LAD ligation
with GTP supplementation (400 mg/Kg/day) for 2 weeks,
with 5 animals per group. Once the rat was anesthetized,
the heart was exposed via a left thoracotomy, and a 6-0
polypropylene suture was tied onto the LAD coronary
artery 3 mm distal to the inferior margin of the left
atrium, and the chest wall was closed in layers. Regional
myocardial ischemia was confirmed by the observation of a
rapid change from reddish to a dark red color on the anter-
ior surface of the LV and rapid development of akinesia and
dilatation in the ligated area. All experimental proceduresconformed to the “Guidelines for Proper Conduct of
Animal Experiments” approved by the Animal Care and
Use Committee of Taichung Veterans General Hospital
and National Chung-Hsing University.
After surgery, the rats were fed intragastrically with
GTPs (400 mg/kg) every day for two weeks. After the
rats were sacrificed, the hearts were cut along the long
cross-sectional axis of the left ventricle, and cardiac
tissues at both the infarcted area and a remote site of
myocardium were isolated to determine protein levels of
the 67 kD laminin receptor and Cav-1 and-3 by immuno-
blotting, as described above.
Statistical analysis
Quantitative values are presented as the mean and standard
error of the mean (mean ± SEM). A difference was con-
sidered to be statistically significant when the P value
was less than 0.05.
Results
EGCg cardioprotective effects on cell viability, ROS
formation, and cytosolic Ca2+ overload in H2O2-treated
H9c2 cells
Previously, we have demonstrated that pre-treatment with
green tea extract protects cardiomyocytes from regional
myocardial ischemia by overcoming cytosolic Ca2+ over-
load, myofibril disruption, and alterations in adherens and
gap junction protein levels and distribution in rats [4].
In the present study, we used a cell model of H9c2 rat
cardiomyoblast to verify the cardioprotection of EGCg
against the H2O2-induced oxidative stress during myocar-
dial ischemia assault. When exposed to 400 μM H2O2, an
increase in oxidative stress caused morphological changes
in H9c2 cells, which were accompanied by an increase
in cell death that was prevented by 20 μM EGCg pre-
treatment for 30 min (Figure 1a). Note that EGCg alone
did not significantly alter cell morphology (Figure 1a).
In addition, the MTT assay showed a dose-dependent
decrease in cell viability of H9c2 cells treated with H2O2
from 100 to 400 μM (Figure 1b). EGCg pre-treatment
with 10 or 20 μM for 30 min did not improve viability
in cells treated with 100 or 200 μM H2O2, but a 25%
recovery of cell viability was observed after exposure to
400 μM H2O2 (Figure 1b). Measurements of intracellular
ROS formation in H9c2 cells demonstrated that 5 to 50 μM
EGCg attenuated 30% ROS formation in H2O2-treated
cells (Figure 1c). Measurements of the fura-2 F340/F380
fluorescence ratio of these cells also indicated that EGCg
could attenuate the cytosolic Ca2+ in H9c2 cells with or
without H2O2 exposure (Figure 1d). The cellular Ca
2+
concentrations (μM) for the cells cultured were 0.17 ± 0.01
in the control medium, 0.12 ± 0.01 in the medium contain-
ing 20 μM EGCg for 30 min, 0.23 ± 0.004 in the medium
containing 400 μM H2O2 for 30 min, and 0.16 ± 0.004
Figure 1 A cell model illustrating cardioprotection of EGCg on H2O2-induced oxidative stress in H9c2 cells. (a) Phase contrast microscopy
showing cell morphology of H9c2 cells in the conditions of control (left top), 20 μM EGCg treatment for 30 min (right top), 400 μM H2O2
exposure for 30 min (left bottom), and 20 μM EGCg pre-treatment for 30 min followed by 400 μM H2O2 exposure for 30 min (right bottom).
Calibration bar of 200 μm as indicated. (b) MTT assay of cell viability after incubation with 0, 100, 200, and 400 μM H2O2 with or without 0, 10, and
20 μM EGCg for 30 min. (c) Measurements of intracellular ROS formation by DCF-DA in H9c2 cells. The fluorescence changes of DCF-DA-loaded cells
were measured every 10 min before and after the addition of 400 μM H2O2 with 0-50 μM EGCg as indicated by fluorescence spectrophotometry. The
fluorescence excitation maximum for DCF-DA was 495 nm, and the corresponding emission maximum was 527 nm. (d) Effects of H2O2 and/or EGCg
on intracellular Ca2+ levels in H9c2 cells. Cellular Ca2+ levels were measured using the Fura-2 fluorescence ratio (F340/F380) in H9c2 cells cultured in
the conditions of control, 20 μM ECGg treatment for 30 min, and 400 μM H2O2 exposure for 30 min with and/or without 20 μM ECGg treatment for
30 min, then during the measurement in PBS for 3 min periods. The F340/F380 ratio was continuously monitored. In b, c and d, the values are the
mean ± SEM (n = 6), with *, # indicating a significant difference compared to the untreated cells or the H2O2-treated cells, respectively.
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followed by 20 μM EGCg treatment for 30 min, re-
spectively (Figure 1d).
Effects of EGCg and H2O2 on the protein levels of
N-cadherin, β-catenin, and phosphorylated and
non-phosphorylated Cx43 in H9c2 cells
To determine whether EGCg has a protective effect
on changes in adherens and gap junction proteins in
H2O2-treated H9c2 cells, we examined the effect of
EGCg on differential expression of the adhesion mole-
cules N-cadherin and β-catenin, and the gap junction
protein Cx43 in H2O2-treated H9c2 cells (Figure 2).
Western blot analysis revealed a decrease in N-cadherin(42.9%) and β-catenin (42.3%) protein content in cells
exposed to H2O2 for 30 min compared to controls, but
not in EGCg-pre-treated cells with or without H2O2
(Figure 2a). To measure levels of phosphorylated and
non-phosphorylated Cx43 in cells, two different anti-
bodies were used. Mouse monoclonal anti-rat-Cx43
antibody labelled one band with a molecular weight of
43 kD (Figure 2b), and the intensity of this band was
reduced in H2O2-exposed cells with (59%) or without (64%)
EGCg pre-treatment compared to controls (Figure 2b).
The rabbit polyclonal anti-Cx43 antibody is known to
recognize both phosphorylated (pCx43, 43 kD) and non-
phosphorylated (nCx43, 41 kD) Cx43 isoforms on poly-
acrylamide gels [4,25]. The intensity of phosphorylated
Figure 2 Effects on the levels of β-catenin, N-cadherin, and Cx 43
in H9c2 cells. (a)Western blotting (top) with quantitative analyses
(bottom) of N-Cadherin, β-catenin, and β-actin levels in the H9c2 cells
of controls with (lane 2) or without (lane 1) 20 μM EGCg pre-treatment
for 30 min or 400 μM H2O2-induced oxidative stress for 30 min with
(lane 4) or without (lane 3) 20 μM EGCg pre-treatment. (b) Top: Cx43
levels on western blots using mouse monoclonal anti-rat Cx43
antibody (sc-13558) or rabbit polyclonal antibodies (71-0700) in the
H9c2 cells of controls with (lane 2) or without (lane 1) 20 μM EGCg
pre-treatment for 30 min or 400 μM H2O2-induced oxidative stress for
30 min with (lane 4) or without (lane 3) 20 μM EGCg pre-treatment.
Bottom: Quantitative analyses using β-actin as the loading control.
In a and b, the values are the mean ± SEM (n = 6), with *, # indicating
a significant difference compared to the untreated cells or the
H2O2-treated cells, respectively.
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pre-treatment (17% decrease) but not changed with EGCg
pre-treatment compared to controls (Figure 2b). In
contrast, the intensity of non-phosphorylated nCx43
was increased in H2O2-treated cells without EGCg pre-
treatment (77%) but decreased with EGCg pre-treatment
(22%) compared to controls (Figure 2b). This result sug-
gests that the H2O2-induced oxidative stress might cause
destruction of gap junction formation by increasing the
levels of non-phosphorylated nCx43 in cardiac cells, while
EGCg pre-treatment could attenuate such damage on the
gap junction assembly in H2O2-treated cells.
Effects of EGCg and H2O2 on the cell cycle and
phosphorylated and GSK-3β, β-catenin, and cyclin D1
protein levels in H9c2 cells
Flow cytometry revealed that the incubation with 400 μM
H2O2 for 30 min blocked DNA synthesis and G1 entry
into the S phase of the cell cycle in H9c2 cells (Figure 3a).
After H2O2 treatment, the number of cells in G0/G1 phase
increased by 5%, but the number in S phase and in G2
phase decreased by 16% and 36%, respectively, compared
to controls. The corresponding values for EGCg treatment
with or without H2O2 were not significantly different from
controls (Figure 3a).
Glycogen synthase kinase 3β (GSK-3β) is a key component
of multiple signalling pathways involved in the regula-
tion of cell fate, protein synthesis, glycogen metabolism,
cell mobility, proliferation, and survival [26-28]. By
preventing cells from entering the cell cycle, GSK-3β
participates in the regulation of the β-catenin signalling
pathway by modulating cyclin D1 expression levels [29].
For cells treated with 400 μM H2O2, phosphorylation of
GSK-3β (Tyr216) was increased by 20%, whereas EGCg
pre-treatment with or without H2O2 attenuated both total
and phosphorylated GSK-3β levels in cells (Figure 3b).
In addition, H2O2 decreased β-catenin (42%) and cyclin D1
(26%) expression levels (Figure 3c), which may cause the
subsequent cell cycle arrest at the G1-S phase (Figure 3a).
This H2O2-induced inhibition of the β-catenin/cyclin D1
signalling pathway could be efficiently prevented by pre-
treatment with 20 μM of EGCg (Figure 3c) or ~10 μM of
SB 216763, an inhibitor of GSK-3α/3β (Figure 3d).
EGCg-induced fluorescence changes in intact Triton
X-100-soluble and insoluble fractions of EGFP-expressing
H9c2 cells
To investigate the role of EGCg-mediated transmembrane
signalling in cardioprotection, EGFP was ectopically
expressed in H9c2 cells. Fluorescence spectroscopy indicated
that increases in EGCg concentrations from 0 to 100 μM
caused dose-dependent decreases in EGFP fluorescence
(Figure 4a). In addition, this experimental approach allowed
us to monitor the fluorescence changes as a means to
Figure 3 Effects on the cell cycle, and phosphorylated GSK-3β, GSK-3β, β-catenin, and cyclin D1 in H9c2 cells. (a) Top: Cell cycle phase
determined by flow cytometry for H9c2 cells in the control medium (left top, label C), or in the medium containing 20 μM EGCg for 30 min
(right top, label E), or in the medium containing 400 μM H2O2 for 30 min with (right bottom, label E + H) or without 20 μM EGCg pretreatment for
30 min (left bottom, label H). Bottom: Quantitative analysis of the cell cycle phase. (b) Western blotting (top) with quantitative analyses (bottom) of
pGSK-3β, GSK-3β, and GAPDH levels for the H9c2 cells cultured in the medium as indicated. (c) Western blotting (top) with quantitative analyses
(bottom) of β-catenin, cyclin D1, and β-actin levels for the H9c2 cells in the medium with the addition as indicated. (d) Western blots showing
inhibition of GSK-3β on β-catenin levels in the H9c2 cells. Lane 1: cells cultured in the control medium; lane 2: cells cultured in the medium containing
20 μM EGCg for 30 min; lane 3: cells cultured in the medium containing 400 μM H2O2 for 30 min, lane 4: cells cultured in the medium containing
400 μM H2O2 for 30 min with 20 μM EGCg pre-treatment for 30 min, lane 5: cells cultured in the medium containing 400 μM H2O2 for 30 min with the
pretreatment of 10 μM SB 216763 inhibitor of GSK-3α/3β for 30 min. In a, b, and c, the values are the mean ± SEM (n = 6), with *, # indicating a
significant difference compared to the cells in control medium and the cells treated with H2O2, respectively.
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Figure 4 EGCg-induced fluorescence changes in EGFP-expressing H9c2 cells and molecular identification on the EGFP-conjugated
protein complex. (a) Fluorescence spectra showing the dose effect of EGCg on EGFP fluorescence. (b) Normalized EGFP fluorescence in the
absence or presence of 0.1% Triton X-100. Fluorescence spectroscopy was performed as described in the Materials and Methods. The fluorescence
emitted at 507 nm measured in the absence of EGCg was used to normalize the fluorescence changes caused by EGCg titrations. Each value is
the mean of six measurements. (c) The EGFP co-precipitated proteins were separated by one-dimensional SDS-PAGE or (d) two-dimensional
electrophoresis (2-DE), followed by proteomics acquiring MALDI-MS spectra. A co-immunoprecipitation assay reveals molecular identities by
immunoblotting (IB) of the protein complexes (i.e., LR, β-actin, GAPDH, Cav-1 and -3) formed with EGFP in these cells.
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soluble compartments on cell membrane (Figure 4b).
To identify the protein complexes conjugated to EGFP
in EGFP-expressing cells, a co-immunoprecipitation assay
using a specific antibody against EGFP was used for
molecular identification, followed by immunoblotting or
MS spectra. The EGFP co-immunoprecipitated proteins
separated by one-dimensional SDS-PAGE (Figure 4c,
Additional file 1: Figure S1) or 2-D electrophoresis
(Figure 4d) were myosin IX [myh 9, 200 kD, EDM15905],
67 kD laminin receptor [LR, 67 kD, 48 kD], vimentin
[53.7 kD, NP112402], β-actin [43 kD, ABM16832)],
GAPDH (36 kD), Cav-3 (24 kD) and Cav-1 (21 kD). LR
has been identified as a receptor for EGCg [30]. Cav-1and -3 are known to stabilize lipid raft microdomains
(Triton X-100-resistant compartment) on cell membranes
[31,32]. Cytoskeletal proteins including β-actin, myosin IX,
and vimentin may form complexes with other protein in cel-
lular Triton X-100-resistant microdomains, which may play
a role in EGCg transmembrane signalling in cardiac cells.
Effects of H2O2 and EGCg on the expression of Cavs in
H9c2 cells
H9c2 cells expressed mRNA encoding Cav-1, Cav-2 and
Cav-3, with a dominant Cav-1 expression (Figure 5a).
Exposure to 400 μM H2O2 with (EH) or without 20 μM
EGCg pre-treatment (H) did not show significant effects on
mRNA expression for any isoform as compared to controls.
Figure 5 Effects of H2O2 and/or EGCg on the expression of Cav in H9c2 cells. (a) Agarose gels demonstrating the presence of mRNAs
encoding different Cav isoforms (Cav-1, Cav-2, and Cav-3) (left), and a histogram showing the Cav isoform mRNA levels relative to those of
GAPDH mRNA in cells exposed to 0.4 mM H2O2 with (EH) or without 20 μM EGCg pretreatment (H) (right). (b) Immunoblot analysis reporting
the protein levels of Cav-1 and phosphorylated Cav-1in whole cell lysates of H9c2 cells cultured in the medium as indicated. GAPDH was used as
the internal control for data analysis. In a and b, each value is the mean ± SEM (n = 6). *indicates significant difference compared to H9c2 cells in
control condition (C), and # symbolizes a significant difference compared to cells treated with H2O2 (H).
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in whole-cell lysates were not significantly changed by
H2O2 and/or EGCg (data not shown). H2O2 induced a 30%
decrease in the levels of Cav-1 concomitant with a 20%
decrease in phosphorylated Cav-1. These decreases were
abrogated by pre-treatment with 10 or 20 μM EGCg for
30 min (Figure 5b). For cells with EGCg treatment for
30 min, the levels of Cav-1 and phosphorylated Cav-1
were increased by 12% and 15%, respectively.
Effects of LAD ligation and GTP treatment on the protein
content of LR and Cav-1 and -3 in rat myocardium
Using a rat model of LAD ligation-induced myocardial
ischemia, we demonstrated the effects of GTP treatment
for 2 weeks on the expression of LR and Cav-1 and -3 inthe myocardium (Figure 6). Two bands with molecular
weights of 43 and 67 kD were labelled for LR and at 21 kD
for Cav-1. The band intensities for LR and Cav-1 were
not significantly different in sham controls and post-
LAD ligation with or without 2-week GTP treatment. In
contrast, one major band appeared at 24 kD for Cav-3,
which was significantly reduced in infarcted myocardium
(46%) but not significantly different in remote myocardium
after ligation without GTPs compared to sham controls.
In post-LAD-ligated rats treated with GTPs for 2 weeks,
the band intensity for Cav-3 in both infarcted and remote
myocardium was similar to sham controls. This result sug-
gests that the expression of Cav-3 is involved in signalling
events for GTP-mediated cardioprotection against myocar-
dial ischemic injury.
Figure 6 Effects of LAD ligation and GTPs on the myocardial
content of LR, Cav-1, and Cav-3. (a) Western blotting with (b)
quantitative analyses of 67 kD laminin receptor, Cav-1, and Cav-3 in
the myocardium of sham controls (lane S) or post-LAD ligated rats
with GTP supplementation (lanes 1, 2) or with water (lanes 3, 4) for
14 days. For post-LAD ligated rats supplemented with GTPs or water,
cardiac tissues at the infarcted area (lanes 2, 4) and a remote myocardial
site (lanes 1, 3) were isolated for analysis. Each group contains 5 animals
for data analyses. The values are the means ± SEM, with *indicating a
significant difference compared to the sham controls.
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pathway in H9c2 cells
Myocardial Akt signalling pathway is known to play an
important role in the regulation of many cellular functions
including growth, survival, proliferation, metabolism, glu-
cose uptake, gene expression, and cell-cell communication
[33]. To examine whether the Akt pro-survival pathway
associated with GSK-3β signalling takes part in EGCg-
mediated cardoioprotection in an H2O2-induced H9c2
cardiomyoblast injury, we determined effects of H2O2 and
EGCg on the Akt phosphorylation at ser-473 and its
downstream substrate GSK-3β phosphorylation at ser-9 in
H9c2 cells by western blot analysis (Figure 7a). Treatment
with 20 μM EGCg for 30 min decreased 14% pAkt (S473)
in concomitant with 15% increase of total Akt and 15%
decrease of pGSK-3β (S9) in H9c2 cells. Incubation with
400 μM H2O2 alone for 30 min did not show significant
effects on the level for pAkt (S473), total Akt, and pGSK-3β
(S9) in cells. However, for cells pre-treated with EGCg
for 30 min in prior to H2O2 exposure, the levels of pAkt
(S473), total Akt, and pGSK-3β (S9) were increased by 2.1
folds, 18% and 2.7 folds, respectively. This suggested thatcellular survival induced by EGCg converges on Akt activa-
tion such as to blockade of GSK-3β activity and initiation of
protective signalling events in H2O2-induced H9c2 cells.
To further establish the relationship between Cav and
GSK-3β signalling pathway, we determined the effects of
GSK-3β inhibition on the phosphorylation of Cav-1 in
H2O2-induced H9c2 cells (Figure 7b). For cells exposed to
400 μM H2O2, phosphorylation of pGSK-3β (S9) and pCav-
1(Y14) was decreased, whereas EGCg or GSK-3β inhibitor,
SB 216763 pre-treatment increased phosphorylation of
both pGSK-3β (S9) and pCav-1(Y14) in H2O2-exposed cells
(Figure 7b). Concomitantly, the H2O2,-suppressed cell
viability of H9c2 was improved by EGCg and/or GSK-3β
inhibitor, SB 216763 pre-treatment (Figure 7c) Apparently,
EGCg mediated Cav-1 signalling through activation on
Akt/GSK-3β might act to protect cardiac cells against
the H2O2-induced oxidative stress in H9c2 cells.
Discussion
Oxidative stress describing an imbalance between the
generation and clearance of reactive oxygen species
(ROS) in cells has the causative effect on the development
and progression of heart disease [34,35]. A cell line of H9c2
rat cardiomyoblasts has been used as an in vitro cellular
model for cardiac tissues in response to oxidative stress
conditions [36]. In addition, H9c2 cells associated with
H2O2-induced oxidative stress have been widely used to
evaluate the protective role of EGCg against oxidative
injury and cell death caused by ROS in cardiac cells [37]. In
the present study, we demonstrated the cardioprotection
effects of EGCg against H2O2-induced oxidative stress in
H9c2 cells by preventing ROS formation and cytosolic Ca2+
overload (Figure 1). This is consistent with the finding by
Dreger et al. [5], which demonstrated that EGCg treatment
for 30 min significantly reduced intracellular levels of ROS
in a model of H2O2-induced oxidative stress in neonatal rat
cardiomyocytes.
Using the H9c2 cell model of H2O2-induced oxidative
stress for a proteomics study, Chou et al. [36] showed
that oxidative stress triggers tyrosine phosphorylation
on target proteins associated with cell-cell junctions,
the actin cytoskeleton, and cell adhesion in cardiac
cells. Previously utilizing a surgical model of IR involving
a temporary LAD ligation in rats, we demonstrated that
green tea polyphenol (GTP) pre-treatment protects cardi-
omyocytes from IR injury by altering the expression and
distribution of adherens and gap junction proteins [4]. In
agreement with previous findings, the present study vali-
dated that EGCg has a protective effect on H2O2-induced
changes in protein expression for the adherens molecules
of β-catenin and N-cadherin and the gap junction protein
Cx43 in H9c2 cells (Figure 2).
GSK-3β relevant to mitochondrial signalling has emerged
as a key end-effector of multiple signalling pathways
Figure 7 The Akt pro-survival pathway associated with GSK-3β signalling takes part in EGCg-mediated Cav-1 activation. (a)Western blotting
with quantitative analyses of Akt phosphorylation at ser-473 and its downstream substrate GSK-3β phosphorylation at ser-9 in H9c2 cells. (b) Immunoblot
analysis showing effects of EGCg and/or GSK-3β inhibition by GSK-3α/3β inhibitor, SB 216763, on the phosphorylation of pGSK-3β (S9) and pCav-1
(Y14) in H2O2-induced H9c2 cells. (c) MTT assay showing the improvement of H2O2,-suppressed cell viability by EGCg and/or GSK-3β inhibitor, SB
216763 pre-treatment in H2O2-induced H9c2 cells. In a and b, each value is the mean ± SEM (n = 6). *indicates significant difference compared to H9c2
cells in control condition, and # symbolizes a significant difference compared to cells treated with H2O2 (H). In a and c, each value is the mean ± SEM
(n = 6). *indicates significant difference compared to H9c2 cells in control condition, # symbolizes a significant difference compared to cells treated
with H2O2, and $ represents a significant difference compared to cells pretreated with EGCg in prior to H2O2 treatment.
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EGCg pre-treatment could protect the H2O2-induced
cell cycle arrest at the G1-S phase by decreasing tyr216
phosphorylation of GSK-3β, leading to the subsequent
increase in β-catenin and cyclin D1 protein expression
in H9c2 cells (Figure 3). β-catenin is a transcriptional
activator of target genes in the nucleus [38,39]. Cyclin D1
is one of target genes that may be activated by β-catenin for
cell proliferation [29]. EGCg modulation of the GSK-3β/
β-catenin/cyclin D1 signalling pathway would therefore
promote the cardiac cell cycle progression into S phase.
Many of the properties of lipid rafts have been inferred
from detergent-resistant membranes that occur in non-
ionic detergent (e.g., Triton X-100) lysates of cells [32].
In the present study, we determined the EGCg-induced
fluorescence changes in intact, Triton X-100-soluble and
insoluble fractions of these cells (Figure 4). Along with the
molecular identification for the protein complexes with
EGFP in these cells, these data suggested that the lipid raft
microdomain-associated proteins (i.e., LR, Cav-1 and Cav-3)
as well as cytoskeletal proteins (i.e., β-actin, myosin IX,
and vimentin) may play a role in EGCg transmembrane
signalling in cardiac cells. Both intact microtubules
and actin filaments have been shown to be the primary
interacting partners of lipid rafts [15,31,32]. There is
increasing evidence that lipid rafts in the cell mem-
brane are clustered in response to different stimuli to
form signalling platforms for transmembrane transduction
[40]. Among these signalling platforms, Zhang et al. [41]reported that some large redox signalling molecules are
recruited into lipid raft microdomains and subsequently
produce ROS in bovine coronary arterial endothelial
cells. The present study comparing the binding of EGCg to
EGFP-expressing cells in conditions with or without
H2O2-induced oxidative stress indicated that the strength of
EGCg binding to cells exposed to H2O2-induced oxidative
stress conditions doubled compared to controls without
H2O2 exposure (Figure 5). It appears that oxidative stress-
induced cardiac cells increase lipid-raft signalling for the
binding of EGCg. Accordingly, these rafts could function
as platforms to mediate the EGCg intracellular signalling
for cardioprotection against oxidative stress.
Increasing evidence indicates that multiple signal
transduction events in the heart occur via caveolae and
caveolins (Cavs) to localize signalling molecules and recep-
tors in the membrane for cardioprotection [10,11,18,19].
Both Cav-1 and Cav-3, functioning as scaffolding proteins,
can provide direct temporal and spatial regulation with
signalling molecules activated by a wide spectrum of
cardioprotective agents including the volatile anesthetic
isoflurane [17,18]. Cav-1 has been shown to play a signalling
role in cardiomyocytes [18]. In contrast, Cav-3, the
muscle-specific isoform, mediates interactions with cytoskel-
etal elements and is responsible for caveolae formation in
cardiac cells [42]. Several myocardial pathologies have been
shown to be associated with alterations in Cav expression:
Cav-1 and Cav-3 levels are elevated in pressure-overloaded
and failing hearts [43,44], whereas reduced cardiac Cav-1
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myocardial infarction [45], cardiac hypertrophy [46],
heart failure [47], and chronic hypoxia [48]. Cav-1 levels are
also altered in renal failure [49] and pulmonary hyperten-
sion [45]. In the present study, using in vitro H2O2-induced
oxidative stress in H9c2 cells, we demonstrated that H2O2
caused a 30% decrease in the levels of Cav-1 concomitant
with a 20% decrease in phosphorylated Cav-1, and these
reductions were counteracted by 10 or 20 μM EGCg
pre-treatment for 30 min (Figure 5b). Since pre-treatment
with GSK-3β inhibitor, SB 216763, also blunted the effects
of H2O2 induced oxidative stress on Cav-1 inhibition
(Figure 7b, c), it is very likely that EGCg could act through
GSK-3β to affect Cav-1 signalling in H2O2-induced cells.
The link between Cav-1 activation and GSK-3β signalling
pathway could be achieved by Akt activation (Figure 7a).
Thus, during oxidative stress by myocardial ischemia
assault Cavs can modulate intracellular signalling for
EGCg-medicated cardioprotection via Akt/GSK-3β path-
way. In addition, using a rat model of myocardial is-
chemia involving LAD ligation, we demonstrated that
GTPs treatment for 2 weeks efficiently protected in-
farcted myocardium of LAD-ligated rats from reduced
Cav-3 protein levels (Figure 6). It appears that during
oxidative injury or myocardial ischemia, Cavs can
modulate intracellular signalling for GTP-medicated
cardioprotection.Conclusions
In summary, the results reported here suggested that
GTPs may mediate cardioprotection against oxidative
stress and ischemic injury through caveolae trafficking
via Akt/GSK-3β pathway.Additional file
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